ABHI has taken another important step in supporting UK HealthTech companies do business in the US. Following its launch six months ago, ABHI’s Innovation Hub has proven to be of significant benefit to UK companies. As a result, the Hub will now be expanded to accommodate double the number of organisations.
The Hub is a unique partnership between ABHI and the Dell Medical School at the University of Texas in Austin, offering UK companies a base within the State of Texas to grow their business. With access to Dell’s world-class faculty, the Hub allows companies to take advantage of a network of clinical contacts, hospital systems, investors, and key business groups.
“The adoption and use of innovative technologies is the greatest enabler for delivering population health and value-based care. We are therefore delighted to be working with ABHI and the Innovation Hub members to deliver this”, added Ruben Rathnasingham, Assistant Dean for Health Product Innovation at Dell Medical School. He continued: “it is particularly pleasing to see just how successful this initiative has been, and I look forward to supporting more UK companies across Austin and the wider State.”
The Innovation Hub is a critical part of ABHI’s US Accelerator Programme, which also gives companies complete access to ABHI’s Texas trade missions, designed to forge and develop partnerships across the State with leading clinical communities. In addition, inclusion in the Innovation Hub allows companies to participate in the ‘Texas Health Catalyst,’ a programme designed by the Dell Medical School to foster health research and advance innovation.
Speaking about the partnership, ABHI International Director, Paul Benton said: “We have had so much momentum with the Innovation Hub that we have decided to expand the scheme to enable more companies to benefit from it. Not only are we offering physical space and connections, but the support offered through our network of US-based mentors allows companies to tap into advice and expertise from a group of in-market specialists. It is a great opportunity and we are looking forward to welcoming more UK companies into the Hub over the coming months.”
Commenting on his company’s decision to join the Innovation Hub, Simon Talbot, P3 Medical’s Managing Director said: “This is a great opportunity for us as a company. Being part of the Hub allows us to be in a world-class facility, within an ecosystem of clinicians, investors and mentors whilst we grow our American business.”
East Midlands Academic Health Science Network Managing Director, Professor Mike Hannay added: “Innovation is essential to the future of healthcare around the world and we are committed to building relationships that enable better clinical outcomes and improved patient experiences. The Hub is a great opportunity to make this happen.”
Supporting the initiative, Richard Stone, Chief Executive, Medilink WM added: “The US market is highly prized, but challenging to enter – particularly for SMEs, and in a trading environment dominated by Brexit-related worries, Medilink wholeheartedly supports positive market access initiatives such as the ABHI Innovation Hub.”
Applications to join the Innovation Hub are now being accepted. For further queries, or to apply to join, click here to email Paul Benton.
Visit the Association of British HealthTech Industries (ABHI), by clicking here.
